Closure of trading Window

C 8> CONCORD DRUGS LIMITED Regd. Office & Factory : Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511. (T.S) INDIA. Admin Office : 3-11-451, L B Nagar, Hyderabad - 500074 E-mail : concorddrugsitd@gmail.com Ph.No : +91 9052779505 Website : www.concorddrugs.in To 25.09.2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400 001 Sub: Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Scrip: 538965 Dear Sir/Madam, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, we wish to inform you that the trading window of the Company will remain closed for the purpose of consideration of un-audited financial results (standalone & consolidated) for the quarter and year ending 30t September 2026 from Thursday, 0lst october 2026 till 48 hours after the announcement/declaration of the un-audited financial results. During the period of closure of the Trading Window, all Directors, Designated Employees, Insiders, and their immediate relatives should not enter into any transaction involving the securities of the Company. The trading window will open 48 hours after the announcement/declaration of the audited financial results for the quarter ending 30t September 2026 to the stock exchanges. The date of the Board Meeting shall be intimated to you separately. Thanking you, Yours faithfully, For Concord Drugs Limited S. Nagi Reddy Chairman & Managing Director DIN: 01764665